Showing results (641-650 of 716) with videos related to

Sort By:
Pageof 72
European Journal of Pharmacology|July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitorsN Fox, M Song, J Schrementi, et al.
Annals of Clinical Biochemistry|May 1, 1997
Novel instrumentation for real-time monitoring using miniaturized flow systems with integrated biosensorsR Freaney, A McShane, T V Keaveny, et al.
Plos One|March 8, 2013
Genome-wide ENU mutagenesis in combination with high density SNP analysis and exome sequencing provides rapid identification of novel mouse models of developmental diseaseGeorgina Caruana, Peter G Farlie, Adam H Hart, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|May 22, 2024
The accuracy of prehospital triage decisions in English trauma networks - a case-cohort studyG Fuller, J Baird, S Keating, et al.
Clinical Breast Cancer|December 12, 2025
Do Not Rush to Omit Sentinel Lymph Node Biopsy for Early Breast Cancer PatientsNíamh M Smyth, Alexandra M Zaborowski, Bukola V Bolarinwa, et al.
Journal of Synchrotron Radiation|June 28, 2014
Characterization of spatial coherence of synchrotron radiation with non-redundant arrays of aperturesP Skopintsev, A Singer, J Bach, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
The Medical Journal of Australia|May 4, 2005
Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in AustraliaSamantha L Ginn, Julie A Curtin, Belinda Kramer, et al.
JCI Insight|September 19, 2024
Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunityNune Markosyan, Il-Kyu Kim, Charu Arora, et al.
Pageof 72